Semaglutide Cost & Price Guide
Also sold as: WEGOVY
As a brand-only medication, Wegovy is expensive without insurance. Patients should look for manufacturer savings programs or patient assistance programs to reduce costs.
Per month, without insurance
Only brand-name versions currently available
Discount coupons may reduce out-of-pocket costs
Cost Overview
As a brand-only medication, Wegovy is expensive without insurance. Patients should look for manufacturer savings programs or patient assistance programs to reduce costs.
Generic vs. Brand-Name Price
| Version | Typical Monthly Cost | Notes |
|---|---|---|
| WEGOVY(brand) | $1,200–$1,800/month | Check manufacturer patient assistance programs |
Available Forms & Strengths
Semaglutide is available in the following dosage forms. Prices may vary by form and strength.
Ways to Save on Semaglutide
Prescription Discount Cards
Free discount programs like GoodRx, RxSaver, and NeedyMeds can reduce the cost of semaglutide at most pharmacies. Compare prices before filling.
90-Day Supply
Ordering a 90-day supply through a mail-order pharmacy often costs less per dose than monthly fills. Check with your insurance plan or pharmacy benefit manager.
Patient Assistance Programs
If you're uninsured or underinsured, the manufacturer may offer a patient assistance program (PAP) that provides semaglutide at low or no cost. Visit NeedyMeds.org or the manufacturer's website.
Insurance Coverage
Most insurance plans, including Medicare Part D and Medicaid, cover semaglutide . Coverage and copay amounts vary by plan tier and formulary. Contact your insurance provider or check your plan's drug formulary to confirm coverage.
Find the Best Price
Coupon & Price Comparison
Patient Assistance Programs (PAP)
If you're uninsured, underinsured, or cannot afford semaglutide, these programs may provide it at low or no cost.
Frequently Asked Questions About Semaglutide Cost
What is SEMAGLUTIDE used for?
1 INDICATIONS AND USAGE WEGOVY is indicated in combination with a reduced calorie diet and increased physical activity: • to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight. • to reduce excess body weight and maintain weight reduction long term in: o Adults and pediatric patients aged 12 years and older with obesity o Adults with overweight in the presence of at least one weight-related comorbid condition. Limitations of Use •…
What is the recommended dosage for SEMAGLUTIDE?
2 DOSAGE AND ADMINISTRATION • Administer WEGOVY once weekly as an adjunct to diet and increased physical activity, on the same day each week, at any time of day, with or without meals (2.1). • Inject subcutaneously in the abdomen, thigh or upper arm (2.1). • In patients with type 2 diabetes, monitor blood glucose prior to starting and during WEGOVY treatment (2.1). • Initiate at 0.25 mg once weekly for 4 weeks. Then follow the dosage escalation schedule, titrating every 4 weeks to achieve the maintenance dosage (2.2 , 2.3). • The maintenance dosage of WEGOVY in adults is either 2.4 mg…
How does SEMAGLUTIDE work?
12.1 Mechanism of Action Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1. GLP-1 is a physiological regulator of appetite and caloric intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation. Animal studies show that semaglutide distributed to and activated neurons in brain regions involved in regulation of food intake. The exact mechanism of cardiovascular risk reduction has not been…
Who should not take SEMAGLUTIDE?
4 CONTRAINDICATIONS WEGOVY is contraindicated in the following conditions: • A personal or family history of MTC or in patients with MEN 2 [see Warnings and Precautions ( 5.1 )] . • A prior serious hypersensitivity reaction to semaglutide or to any of the excipients in WEGOVY. Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with WEGOVY [see Warnings and Precautions ( 5.6 )]. • Personal or family history of MTC or in patients with MEN 2 ( 4 ). • Known hypersensitivity to semaglutide or any of the excipients in WEGOVY ( 4 ).
More Semaglutide Information
Medical Disclaimer
The information on RxGuide is intended for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician, pharmacist, or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.